Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

White House Unveils COVID-19 Vaccine Distribution Plan for Children Ages 5 to 11 Upon Approval

10/20/2021 | 04:11pm EST


ę MT Newswires 2021
All news about PFIZER, INC.
09:05aBioNTech Capable of Quickly Modifying Vaccine for Omicron Variant, CEO Says
MT
06:42aBioNTech CEO Expects To Modify COVID-19 Vaccine To Omicron Variant
MT
03:32aMalaysia Confirms First Case of New COVID-19 Variant
MT
01:21aUK jabs deal to 'future-proof' immunisation
AQ
12/02Pfizer Taps Amazon Web Services To Boost Clinical Manufacturing Via Cloud-Based Solutio..
MT
12/02WRAPUP 6-WHO chief scientist urges people not to panic over Omicron
RE
12/02Pfizer-BioNTech, Moderna's COVID-19 Jabs Offer Best Immunity Boost, UK Study Says
MT
12/02U.S. administers 464.4 mln doses of COVID-19 vaccines - CDC
RE
12/02Wall Street ends higher in robust rebound from Omicron-driven rout
RE
12/02DOJ, SEC Charge Former Immunomedics Finance Chief With Insider Trading
DJ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 517 M - -
Net income 2021 21 354 M - -
Net Debt 2021 27 873 M - -
P/E ratio 2021 13,6x
Yield 2021 2,97%
Capitalization 298 B 298 B -
EV / Sales 2021 3,99x
EV / Sales 2022 3,76x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 53,04 $
Average target price 49,58 $
Spread / Average Target -6,53%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.44.09%297 706
JOHNSON & JOHNSON-0.18%413 555
ROCHE HOLDING AG17.62%341 509
NOVO NORDISK A/S64.51%243 534
ELI LILLY AND COMPANY47.55%224 726
ABBVIE INC.8.18%206 612